-
1.发明公开ENANTIOMERENREINE BETAAGONISTEN, VERFAHREN ZU DEREN HERSTELLUNGEN UND DEREN VERWENDUNG ALS ARZNEIMITTEL 审中-公开对映异构β受体激动剂筹备工作他们的方法和它们作为药物
公开(公告)号：EP2057134A1
公开(公告)日：2009-05-13
申请号：EP07802746.3
申请日：2007-08-21
发明人： KONETZKI, Ingo , SIEGER, Peter
IPC分类号： C07D265/18 , A61K31/536 , A61P11/06 , A61P11/08
CPC分类号： C07D265/18
摘要： The invention relates to single enantiomer compounds of formula (1), where the groups R1, R2, R3, m and Ym- can have the meanings given in the claims and description, method for production and use thereof as a medicament, in particular as medicament for the treatment of airway diseases.
-
2.发明公开NEUE INDOL-HALTIGE BETA-AGONISTEN, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL 审中-公开吲哚含有β-激动剂，方法及其及其作为药物
公开(公告)号：EP1943220A2
公开(公告)日：2008-07-16
申请号：EP06807619.9
申请日：2006-10-27
发明人： TRIESELMANN, Thomas , WALTER, Rainer , NETHERTON, Matthew R. , KONETZKI, Ingo , SANTAGOSTINO, Marco , HAMILTON, Bradford S.
IPC分类号： C07D209/08 , C07D209/18 , C07D209/42 , C07D401/12
CPC分类号： C07D209/08 , C07D209/18 , C07D209/42 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12
摘要： The invention relates to the novel beta agonists of formula (I), wherein R1 and R2 are defined as in the claims and the description. The invention also relates to the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, or mixtures thereof, to their prodrugs and their salts, especially their physiologically acceptable salts with inorganic or organic acids or bases, to a method for producing said compounds and to their use as drugs.
-
公开(公告)号：EP1856070A1
公开(公告)日：2007-11-21
申请号：EP06708325.3
申请日：2006-02-16
IPC分类号： C07D265/18 , A61K31/536
CPC分类号： C07D265/18
摘要： The invention concerns the use of compounds of formula (I), wherein the radicals R1, R2 and R3 are such as defined in the description and the claims, for producing a drug for treating respiratory diseases as well as novel compounds of formula (I). The invention also concerns a method for producing said compounds, and pharmaceutical formulations containing them.
-
4.发明公开NEUE BENZOXAZINONDERIVATE ALS LANGWIRKSAME BETAMIMETIKA ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN 有权新BENZOXAZINONDERIVATE AS呼吸系统疾病治疗的长效β受体兴奋剂
公开(公告)号：EP1730126A1
公开(公告)日：2006-12-13
申请号：EP05715856.0
申请日：2005-03-09
IPC分类号： C07D265/36 , A61K31/536 , A61P11/00
CPC分类号： C07D265/36
摘要： The invention relates to compounds of general formula (I) in which radicals R, R1, R2, R3 and A can have the meanings as cited in the claims and in the description, to methods for the production thereof, and to their use as medicaments, particularly for treating inflammatory and obstructive respiratory illnesses.
-
5.发明公开NEUE LANGWIRKSAME ARZNEIMITTELKOMBINATIONEN EIN ANTICHOLINERGIKUM UND EINEN BETA-2-ADRENOREZEPTORANTAGONISTEN ENTHALTEND ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN 审中-公开NEW LONG有效的药物和它们的组合抗胆碱能β-2肾上腺素能受体拮抗剂CONTAINING呼吸系统疾病的治疗
公开(公告)号：EP1631287A2
公开(公告)日：2006-03-08
申请号：EP04739209.7
申请日：2004-05-14
发明人： KONETZKI, Ingo
CPC分类号： A61K9/0075 , A61K9/008 , A61K31/46 , A61K31/63 , A61K2300/00
摘要： The invention relates to novel medicament compositions based on a novel anticholinergic agent and a novel long-acting β2-agonist. The invention also relates to the production and utilization of said compositions in the therapy of respiratory tract diseases.
-
6.发明授权
公开(公告)号：EP1901776B1
公开(公告)日：2012-02-22
申请号：EP06763946.8
申请日：2006-06-28
IPC分类号： A61K45/06 , A61K31/538 , A61P11/08
CPC分类号： A61K45/06 , A61K31/538 , A61K2300/00
摘要： The invention relates to novel medicinal combinations preferably comprising a compound of formula (I), wherein the groups X, Ra, Rb, R1, R1', R2, R2', R2'', R2''', V and n can have a significance specified in claims and in a description, or several of said compounds and at least one type of other active substance 2. Methods for the production of the inventive compounds and the use thereof in the form of drugs are also disclosed.
-
公开(公告)号：EP2094271A2
公开(公告)日：2009-09-02
申请号：EP07802745.5
申请日：2007-08-21
CPC分类号： A61K31/536 , A61K2300/00
摘要： The invention relates to novel drug combinations, comprising, in addition to one or more, preferably one, compound of general formula (1), where the groups R1, R2 and R3 can have the meanings given in the claims and description, at least one further active ingredient 2, a method for production and use thereof as a drug.
摘要翻译： 本发明涉及新的药物组合，其除了一种或多种，优选一种通式（1）的化合物之外，其中基团R 1，R 2和R 3可以具有权利要求和描述中给出的含义，至少一个 进一步的活性成分2，其制备方法及其作为药物的用途。
-
8.发明公开ARZNEIMITTELKOMBINATION FÜR DIE INHALATION ENTHALTEND NEBEN EINEM ANTICHOLINERGIKUM EIN BETAMIMETIKUM UND EIN STEROID 审中-公开药物联合用于吸入含除了抗胆碱能β-模拟和类固醇
公开(公告)号：EP1879571A1
公开(公告)日：2008-01-23
申请号：EP06763047.5
申请日：2006-04-19
IPC分类号： A61K31/40 , A61P11/06 , A61P11/00 , A61K31/573 , A61K31/137
CPC分类号： A61K31/137 , A61K31/40 , A61K31/573 , A61K2300/00
摘要： The invention relates to a novel medicament to be inhaled, said medicament containing at least one, preferably one, anticholinergic agent 1 combined with at least one betamimetic agent 2 and at least one steroid 3. The invention also relates to a method for producing one such medicament, and the use thereof for treating respiratory diseases.
-
9.发明公开HETEROARYLVERBINDUNGEN ALS BETAMIMETKIA ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN 有权杂ALS BETAMIMETKIA呼吸系统疾病的治疗
公开(公告)号：EP1794154A1
公开(公告)日：2007-06-13
申请号：EP05789491.7
申请日：2005-09-15
发明人： KONETZKI, Ingo , BOUYSSOU, Thierry , HOENKE, Christoph , LUSTENBERGER, Philipp , SCHNAPP, Andreas , CEREDA, Enzo
IPC分类号： C07D413/12 , C07D401/12 , A61K31/538 , A61P11/00
CPC分类号： C07D413/12 , C07D401/12
摘要： The invention relates to the compounds of formula (1), wherein n, m, B, X and R1 are defined as in the claims and in the description. The invention also relates to methods for producing them and to their use as drugs, especially as drugs for treating respiratory diseases.
-
10.发明公开
公开(公告)号：EP1761509A2
公开(公告)日：2007-03-14
申请号：EP05747842.2
申请日：2005-05-10
发明人： BOUYSSOU, Thierry , KONETZKI, Ingo , SCHNAPP, Andreas , HOENKE, Christoph , LUSTENBERGER, Philipp , RUDOLF, Klaus , SANTAGOSTINO, Marco
IPC分类号： C07D265/28 , A61K31/538 , C07C215/30 , A61P11/00
CPC分类号： C07D265/28
摘要： The invention relates to the compounds of formula (1), wherein the groups R1, R2, R3, R4, R5, R6, R7, R8, n, m and X are defined as in the claims and in the description. The invention also relates to the use of these compounds as drugs, especially as drugs for use in the treatment of inflammatory and obstructive respiratory diseases.
-
-
-
-
-
-
-
-
-
搜索结果
33 条记录 (耗时 0.034 秒)
